https://www.biopromic.com/global-good-and-biopromic-partner-to-co-develop-low-cost-diagnostic-to-detect-tuberculosis/https://www.biopromic.com/gold-magnetic-particles/https://www.biopromic.com/technologies/https://www.biopromic.com/sample-prep/https://www.biopromic.com/conjugation/https://www.biopromic.com/ultrasensitive-detection-of-lipoarabinomannan-with-plasmonic-grating-biosensors-in-clinical-samples-of-hiv-negative-patients-with-tuberculosis/https://www.biopromic.com/biopromic-in-collaboration-with-asahi-kasei-corp-is-awarded-a-ghit-grant-for-development-of-lfa-platform-for-improving-sensitivity-of-point-of-care-assays-for-infectious-disease-with-main-focus-on-tu/https://www.biopromic.com/biopromic-awarded-medtech-4-health-grant-from-vinnova/https://www.biopromic.com/biopromic-nominated-to-european-health-catapult/